Copy For Citation
Kaya C., Atalay Y. O., Can Meydan B., Üstün Y. B., Köksal E., Çalışkan S.
REVISTA BRASILEIRA DE ANESTESIOLOGIA, vol.69, no.4, pp.403-412, 2019 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
69
Issue:
4
-
Publication Date:
2019
-
Doi Number:
10.1016/j.bjan.2019.03.006
-
Journal Name:
REVISTA BRASILEIRA DE ANESTESIOLOGIA
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.403-412
-
Keywords:
Cyclooxygenase inhibitor, Intrathecal injection, (S)-(+)-Ketoprofen, Neurotoxicity, Inflammation, POSTOPERATIVE PAIN, DICLOFENAC SODIUM, KETOROLAC, DRUGS, CYCLOOXYGENASE-1, LIDOCAINE, TOXICITY, FENTANYL, SAFETY, ADULT
-
Ondokuz Mayıs University Affiliated:
Yes
Abstract
Background and objectives: Intrathecal administration of non-steroidal anti-inflammatory drugs is more efficacious for post-operative pain management. Cyclooxygenase inhibiting nonsteroidal anti-inflammatory drugs like (S)-(+)-Ketoprofen, may be effective at lower intrathecal doses than parenteral ones. Preclinical safety regarding possible neurotoxicity associated with the intrathecal (S)-(+)-Ketoprofen was not evaluated. Here we analysed the neurotoxicity of intrathecally administered (S)-(+)-Ketoprofen in rats.